Propionate-engineered probiotics reduce radiation-induced intestinal damage

Abstract

Radiation enteritis is a common complication in patients undergoing abdominal radiotherapy. Current management strategies face significant limitations: clinical agents like amifostine are hindered by systemic side effects and demanding administration; direct supplementation with radioprotective metabolites such as propionate suffers from low bioavailability and transient action; and conventional probiotics lack targeted therapeutic output. To address these challenges, we engineered Escherichia coli Nissle 1917 to function as a living therapeutic that continuously produces and delivers propionate directly in the gut. This propionate-engineered probiotic achieved a production yield of 181.33±4.27 mg/L in vitro. In a mouse model of abdominal irradiation, this engineered bacterium alleviated radiation-induced intestinal damage by continuously releasing propionate and enhancing intestinal epithelial barrier function. Multi-omics analysis revealed that the engineered bacterium could restore intestinal microbiota homeostasis, enhancing the abundance of advantageous bacteria with radioprotective properties (e.g., Dubosiella, Akkermansia). Moreover, it modulated intestinal microbiota metabolism, influencing the metabolism of ascorbic acid, aldoses, and other metabolites. Additionally, it protected the intestinal mucosal barrier from radiation-induced damage, which was associated with the modulation of the SOCS1/JAK2/STAT3 signaling pathway. This study introduces a novel biological therapy to mitigate the side effects of radiotherapy and could open new avenues for preventing and treating radiation-induced intestinal injury.

Keywords

Radiation / Propionate synthetic biology / Engineered probiotics / Gut / Gut microbiota

References

[1] Abdel-Wahab M, Giammarile F, Carrara Met al.. Radiotherapy and theranostics: a lancet oncology commission. Lancet Oncol, 2024, 25(11): e545-e580

[2] Aboagye EO, Barwick TD, Haberkorn U. Radiotheranostics in oncology: making precision medicine possible. CA Cancer J Clin, 2023, 73(3): 255-274

[3] Adesina PA, Isayama K, Sitolo GCet al.. Propionate and dietary fermentable fibers upregulate intestinal heat shock Protein70 in intestinal Caco-2 cells and mouse colon. J Agric Food Chem, 2021, 69(30): 8460-8470

[4] Andreyev HJ, Wotherspoon A, Denham JW, Hauer-Jensen M. Defining pelvic-radiation disease for the survivorship era. Lancet Oncol, 2010, 11(4): 310-312

[5] Bensemmane L, Squiban C, Demarquay C, Mathieu N, Benderitter M, Le Guen Bet al.. The stromal vascular fraction mitigates radiation-induced Gastrointestinal syndrome in mice. Stem Cell Res Ther, 2021, 12: 309

[6] Bermúdez MA, Pereira L, Fraile C, Valerio L, Balboa MA, Balsinde J. Roles of palmitoleic acid and its positional Isomers, hypogeic and Sapienic acids, in Inflammation, metabolic diseases and cancer. Cells, 2022, 11(14): 2146

[7] Bilotta AJ, Ma C, Yang Wet al.. Propionate enhances cell speed and persistence to promote intestinal epithelial turnover and repair. Cell Mol Gastroenterol Hepatol, 2021, 1141023-1044

[8] Binder HJ, Brown I, Ramakrishna BS, Young GP. Oral rehydration therapy in the second decade of the twenty-first century. Curr Gastroenterol Rep, 2014, 16(3): 376

[9] Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol, 2022, 1910625-637

[10] Cerecedo D, Martínez-Vieyra I, Hernández-Rojo Iet al.. Reactive oxygen species downregulate dystroglycans in the megakaryocytes of rats with arterial hypertension. Exp Cell Res, 2023, 433(2): 113847

[11] Chandrasekaran P, Weiskirchen S, Weiskirchen R. Effects of probiotics on gut microbiota: an overview. Int J Mol Sci, 2024, 25116022

[12] Chen Z, Yong T, Wei Zet al.. Engineered Probiotic-Based personalized cancer vaccine potentiates antitumor immunity through initiating trained immunity. Adv Sci (Weinh), 2024, 113e2305081

[13] Chen Z, Jiang P, Su D, Zhao Y, Zhang M. Therapeutic Inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease. Cytokine Growth Factor Rev, 2024, 79: 1-15

[14] Cong J, Zhou P, Zhang R. Intestinal Microbiota-Derived short chain fatty acids in host health and disease. Nutrients, 2022, 14(9): 1977

[15] Cui M, Xiao H, Li Y, Zhou L, Zhao S, Luo Det al.. Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med, 2017, 9: 448-461

[16] Cui Y, Zhang L, Wang Xet al.. Roles of intestinal parabacteroides in human health and diseases. FEMS Microbiol Lett, 2022, 369(1): 072

[17] De Ruysscher D, Niedermann G, Burnet NGet al.. Radiotherapy toxicity. Nat Rev Dis Primers, 2019, 5: 1

[18] Eshleman EM, Rice T, Potter Cet al.. Microbiota-derived butyrate restricts tuft cell differentiation via histone deacetylase 3 to modulate intestinal type 2 immunity. Immunity, 2024, 572319-332

[19] Feng Y, Luo X, Li Z, Fan X, Wang Y, He RRet al.. A ferroptosis-targeting ceria anchored Halloysite as orally drug delivery system for radiation colitis therapy. Nat Commun, 2023, 14: 5083

[20] Filippone A, Lanza M, Campolo Met al.. The Anti-Inflammatory and antioxidant effects of sodium propionate. Int J Mol Sci, 2020, 21(8): 3026

[21] Fock E, Parnova R. Mechanisms of Blood-Brain barrier protection by Microbiota-Derived Short-Chain fatty acids. Cells, 2023, 124657

[22] Giridhar P, Pradhan S, Dokania S, Venkatesulu B, Sarode R, Welsh JS. Microbiome and abdominopelvic radiotherapy related chronic enteritis: A Microbiome-based mechanistic role of probiotics and antibiotics. Am J Clin Oncol, 2024, 475246-252

[23] Guan X, Li W, Meng H. A double-edged sword: role of butyrate in the oral cavity and the gut. Mol Oral Microbiol, 2021, 36(2): 121-131

[24] Guo H, Chou WC, Lai Yet al.. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites. Science, 2020, 370(6516): eaay9097

[25] Gurbatri CR, Radford GA, Vrbanac Let al.. Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia. Nat Commun, 2024, 151646

[26] Hauer-Jensen M, Denham JW, Andreyev HJ. Radiation enteropathy–pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol, 2014, 118470-479

[27] He KY, Lei XY, Wu DHet al.. Akkermansia muciniphila protects the intestine from irradiation-induced injury by secretion of propionic acid. Gut Microbes, 2023, 15(2): 2293312

[28] Heavey MK, Hazelton A, Wang Yet al.. Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis. Nat Commun, 2024, 1513784

[29] Henneke L, Schlicht K, Andreani NA, Hollstein T, Demetrowitsch T, Knappe Cet al.. A dietary carbohydrate - gut Parasutterella - human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes. Gut Microbes, 2022, 14: 2057778

[30] Henrick BM, Rodriguez L, Lakshmikanth Tet al.. Bifidobacteria-mediated immune system imprinting early in life. Cell, 2021, 184153884-3898

[31] Hu M, Zhang T, Miao M, Li K, Luan Q, Sun G. Expectations for employing Escherichia coli Nissle 1917 in food science and nutrition. Crit Rev Food Sci Nutr, 2024, 8: 1-9

[32] Huang B, Yang H, Fang Get al.. Central pathway engineering for enhanced succinate biosynthesis from acetate in Escherichia coli. Biotechnol Bioeng, 2018, 115(4): 943-954

[33] Jaeggi T, Kortman GA, Moretti Det al.. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut, 2015, 64(5): 731-742

[34] Jia L, Jiang Y, Wu Let al.. Porphyromonas gingivalis aggravates colitis via a gut microbiota-linoleic acid metabolism-Th17/Treg cell balance axis. Nat Commun, 2024, 15(1): 1617

[35] Jian Y, Zhang D, Liu M, Wang Y, Xu ZX. The impact of gut microbiota on Radiation-Induced enteritis. Front Cell Infect Microbiol, 2021, 11: 586392

[36] Jiang T, Du P, Liu Det al.. Exploring the glucose-lowering and anti-inflammatory immune mechanism of Artemether by AMPK/mTOR pathway and Microbiome based on multi-omics. Front Pharmacol, 2025, 16: 1520439

[37] Johanesen PA, Mackin KE, Hutton MLet al.. Disruption of the gut microbiome: clostridium difficile infection and the threat of antibiotic resistance. Genes (Basel), 2015, 641347-1360

[38] Kang G, Wang X, Gao Met al.. Propionate-producing engineered probiotics ameliorated murine ulcerative colitis by restoring anti-inflammatory macrophage via the GPR43/HDAC1/IL-10 axis. Bioeng Transl Med, 2024, 9(5): e10682

[39] Kang G, Zhang B, Wu J, Wang L, Huang H (2025) Engineering probiotics as living biotherapeutics: a novel paradigm of restoring physiological barriers via targeted short-chain fatty acid delivery. Sci China Life Sci

[40] King M, Joseph S, Albert Aet al.. Use of amifostine for cytoprotection during radiation therapy: A review. Oncology, 2020, 98261-80

[41] Kwak SY, Shim S, Park S, Kim H, Lee SJ, Kim MJet al.. Ghrelin reverts intestinal stem cell loss associated with radiation-induced enteropathy by activating Notch signaling. Phytomedicine, 2021, 81: 153424

[42] Kwon YH, Banskota S, Wang Het al.. Chronic exposure to synthetic food colorant allura red AC promotes susceptibility to experimental colitis via intestinal serotonin in mice. Nat Commun, 2023, 14(1): 3125

[43] Lee JY, Tiffany CR, Mahan SPet al.. High fat intake sustains sorbitol intolerance after antibiotic-mediated clostridia depletion from the gut microbiota. Cell, 2024, 18751191-1205e15

[44] Li J, Zhu X, Chen J, Zhao D, Zhang X, Bi C. Construction of a novel anaerobic pathway in Escherichia coli for propionate production. BMC Biotechnol, 2017, 17(1): 38

[45] Li Y, Dong J, Xiao Het al.. Gut commensal derived-valeric acid protects against radiation injuries. Gut Microbes, 2020, 114789-806

[46] Li J, Zhang L, Wu T, Li Y, Zhou X, Ruan Z. Indole-3-propionic acid improved the intestinal barrier by enhancing epithelial barrier and mucus barrier. J Agric Food Chem, 2021, 69(5): 1487-1495

[47] Li W, Wang X, Dong Yet al.. Nicotinamide riboside intervention alleviates hematopoietic system injury of ionizing radiation-induced premature aging mice. Aging Cell, 2023, 22(11): e13976

[48] Liau NPD, Laktyushin A, Lucet ISet al.. The molecular basis of JAK/STAT Inhibition by SOCS1. Nat Commun, 2018, 911558

[49] Liu XF, Shao JH, Liao YTet al.. Regulation of short-chain fatty acids in the immune system. Front Immunol, 2023, 14: 1186892

[50] Liu H, Wang D, Feng Xet al.. Sishen pill & Tongxieyaofang ameliorated ulcerative colitis through the activation of HIF-1α acetylation by gut microbiota-derived propionate and butyrate. Phytomedicine, 2025, 136: 156264

[51] Lu L, Li W, Chen L, Su Q, Wang Y, Guo Zet al.. Radiation-induced intestinal damage: latest molecular and clinical developments. Future Oncol, 2019, 15: 4105-4118

[52] Ma DJ, Li ZJ, Wang XY, Zhu XJ, Sun YL. Octreotide treatment of cancer chemoradiotherapy-induced diarrhoea: a meta-analysis of randomized controlled trials. Transl Cancer Res, 2019, 8(6): 2284-2294

[53] Ma S, Yeom J, Lim YH. Dairy Propionibacterium freudenreichii ameliorates acute colitis by stimulating MUC2 expression in intestinal goblet cell in a DSS-induced colitis rat model. Sci Rep, 2020, 10(1): 5523

[54] Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the Microbiome and immunity. Nat Rev Immunol, 2024, 248577-595

[55] Mao K, Wang X, Hou Yet al.. Integrated network Pharmacology and transcriptomic approach reveal the role of equol in reducing colorectal cancer via regulating multiple cell cycle genes in HCT116 cells. Int J Biol Macromol, 2024, 282(Pt 2): 136832

[56] Miscevic D, Mao JY, Moo Young Met al.. High-level heterologous production of propionate in engineered Escherichia coli. Biotechnol Bioeng, 2020, 11751304-1315

[57] Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The genus alistipes: gut bacteria with emerging implications to Inflammation, Cancer, and mental health. Front Immunol, 2020, 11: 906

[58] Peng K, Xia S, Xiao S, Yu Q. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?. J Gastroenterol Hepatol, 2022, 37(9): 1710-1718

[59] Philips RL, Wang Y, Cheon Het al.. The JAK-STAT pathway at 30: much learned, much more to do. Cell, 2022, 185(21): 3857-3876

[60] Redenti A, Im J, Redenti Bet al.. Probiotic neoantigen delivery vectors for precision cancer immunotherapy. Nature, 2024, 635(8038): 453-461

[61] Salas A, Hernandez-Rocha C, Duijvestein Met al.. JAK-STAT pathway targeting for the treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol, 2020, 17(6): 323-337

[62] Salvi PS, Cowles RA. Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells, 2021, 10(7): 1775

[63] Schmitt MGJr, Soergel KH, Wood CM. Absorption of short chain fatty acids from the human jejunum. Gastroenterology, 1976, 702211-215

[64] Schmitt MGJr, Soergel KH, Wood CM, Steff JJ. Absorption of short-chain fatty acids from the human ileum. Am J Dig Dis, 1977, 22(4): 340-347

[65] Shi Z, Li M, Zhang C, Li H, Zhang Y, Zhang L, Li X, Li L, Wang X, Fu X, Sun Z, Zhang X, Tian L, Zhang M, Chen WH, Li Z. Butyrate-producing Faecalibacterium Prausnitzii suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway. Gut, 2025, 74(4): 557-570

[66] Shin Y, Han S, Kwon Jet al.. Roles of Short-Chain fatty acids in inflammatory bowel disease. Nutrients, 2023, 15(20): 4466

[67] Simpson JB, Walker ME, Sekela JJet al.. Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics. Cell Host Microbe, 2024, 326925-944

[68] Song D, Jia A, Liu Bet al.. Whole-transcriptome analysis after the acquisition of antibiotic resistance of cronobacter sakazakii: mechanisms of antibiotic resistance and virulence changes. Food Res Int, 2023, 174(Pt 2): 113664

[69] Traber MG, Buettner GR, Bruno RS. The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome. Redox Biol, 2019, 21: 101091

[70] Wang W, Geng M, Zhu Cet al.. Protective effects and mechanism of a novel probiotic strain Ligilactobacillus salivarius YL20 against cronobacter sakazakii-Induced necrotizing Enterocolitis in vitro and in vivo. Nutrients, 2022, 14183827

[71] Wang Y, Lai W, Zheng Xet al.. Linderae radix extract attenuates ulcerative colitis by inhibiting the JAK/STAT signaling pathway. Phytomedicine, 2024, 132: 155868

[72] Wang X, Cai Z, Wang Qet al.. Bacteroides methylmalonyl-CoA mutase produces propionate that promotes intestinal goblet cell differentiation and homeostasis. Cell Host Microbe, 2024, 32163-78

[73] Wang K, Yuan B, Zhang Fet al.. A bioadhesive antioxidase-overexpressed probiotic prevents radiation enteritis by scavenging the excess reactive oxygen species. Free Radic Biol Med, 2025, 227: 485-498

[74] Wesener DA, Beller ZW, Hill MFet al.. In vivo manipulation of human gut bacteroides fitness by abiotic oligosaccharides. Nat Chem Biol, 2024, 10: 23

[75] Wu J, Huang H, Wang Let al.. A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation. Gut Microbes, 2024, 16(1): 2316575

[76] Wu J, Ji K, Kang Get al.. Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis. Pharmacol Res, 2025, 213: 107642

[77] Xia J, Cui Y, Guo Y, Liu Y, Deng B, Han S. The function of probiotics and prebiotics on canine intestinal health and their evaluation criteria. Microorganisms, 2024, 1261248

[78] Xu C, Gu L, Hu L et al (2023) FADS1-arachidonic acid axis enhances arachidonic acid metabolism by altering intestinal microecology in colorectal cancer. Nat Commun. ; 14(1): 2042

[79] Yang W, Yu T, Huang Xet al.. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun, 2020, 1114457

[80] Yang W, Yu T, Liu Xet al.. Microbial metabolite butyrate modulates granzyme B in tolerogenic IL-10 producing Th1 cells to regulate intestinal inflammation. Gut Microbes, 2024, 1612363020

[81] Yang HT, Jiang ZH, Yang Yet al.. Faecalibacterium Prausnitzii as a potential antiatherosclerotic microbe. Cell Commun Signal, 2024, 22154

[82] Yao Y, Cai X, Fei W, Ye Y, Zhao M, Zheng C. The role of short-chain fatty acids in immunity, inflammation and metabolism. Crit Rev Food Sci Nutr, 2022, 6211-12

[83] Yao T, Dong X, Lv J, Fu L, Li L. Propionate alleviated colitis by modulating iron homeostasis to inhibit ferroptosis and macrophage polarization. Int Immunopharmacol, 2025, 162: 115151

[84] Ye Z, Tan Q, Woltemate Set al.. Escherichia coli Nissle improves Short-Chain fatty acid absorption and barrier function in a mouse model for chronic inflammatory diarrhea. Inflamm Bowel Dis, 2025, 31(4): 1109-1120

[85] Yu M, Hu S, Tang B, Yang H, Sun D. Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applications. Biotechnol Adv, 2023, 67: 108202

[86] Zhang F, He F, Li Let al.. Bioavailability based on the gut microbiota: a new perspective. Microbiol Mol Biol Rev, 2020, 84(2): e00072-e00019

[87] Zhang X, Zhang H, Huang Met al.. Ferulic acid interferes with radioactive intestinal injury through the DJ-1-Nrf2 and Sirt1-NF-κB-NLRP3 pathways. Molecules, 2024, 29215072

[88] Zhang Y, Tu S, Ji X, Wu J, Meng J, Gao Jet al.. Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway. Nat Commun, 2024, 15: 1333

[89] Zhao H, Zhou Y, Xu Jet al.. Short-chain fatty acid-producing bacterial strains attenuate experimental ulcerative colitis by promoting M2 macrophage polarization via JAK/STAT3/FOXO3 axis inactivation. J Transl Med, 2024, 221369

[90] Zhao M, Cui M, Fan Met al.. Octreotide attenuates experimental severe acute pancreatitis through inhibiting pyroptosis and modulating intestinal homeostasis. Eur J Pharmacol, 2025, 994: 177314

[91] Zhou J, Li M, Chen Qet al.. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun, 2022, 1313432

[92] Zhou H, Zhou YL, Mao JA, Tang LF, Xu J, Wang ZXet al.. Corrigendum to NCOA4-mediated ferritinophagy is involved in ionizing radiation-induced ferroptosis of intestinal epithelial cells. Redox Biol, 2024, 77: 103377

[93] Zhuang H, Ren X, Jiang F, Zhou P. Indole-3-propionic acid alleviates chondrocytes inflammation and osteoarthritis via the AhR/NF-κB axis. Mol Med, 2023, 29117

Funding

the National Key Research and Development Program of China(2024YFA0918500)

RIGHTS & PERMISSIONS

The Author(s)